Home

IPO Allotment

IPO GMP

IPO News

Get App

Revolutionising IPO investing with a seamless and secure platform for maximising your IPO allotment chances.

DISCLAIMER

Envest is not a SEBI-registered advisor. We do not provide any investment advice or recommendation.

IPO TOOLS

IPO Dashboard
GMP Tracker
Subscription Status
Listing Performance
Allotment Status

RESOURCES

IPO Reviews
IPO News
Download App
Contact

DOWNLOAD APP

Revolutionising IPO investing with a seamless and secure platform for maximising your IPO allotment chances.

DOWNLOAD APP

LEGAL

DISCLAIMER

Envest is not a SEBI-registered advisor. We do not provide any investment advice or recommendation.

Nephrocare Health Services Ltd. IPO IPO Review - Coming Soon | Envest

IPO/Reviews/Nephrocare Health Services Ltd. IPO

Back to IPO Reviews

Nephrocare Health Services Ltd. IPO

Listed

Mainboard

Price Range:

₹460.00

Issue Size:

₹871.05 Cr

Lot Size:

32 shares

IPO Dates:

Dec 10, 2025 - Dec 12, 2025

Review Coming Soon

Our team of expert analysts is actively working on a comprehensive review and analysis of Nephrocare Health Services Ltd. IPO IPO. We're preparing detailed investment insights just for you!

Expert analysis in progress

What to Expect in Our Review

Expert Rating

Comprehensive 5-star rating with clear investment recommendation

Financial Analysis

In-depth analysis of company fundamentals and valuation metrics

Risk Assessment

Detailed risk analysis and investment considerations

Current Market Insights

₹40

Grey Market Premium

₹40

Estimated Listing Price

+8.7%

Expected Listing Gain

View Full IPO Details Check GMP Analysis View Subscription Status Back to All Reviews

Note: This IPO review is currently being prepared by our expert team. The information shown above is for reference only. Please check back soon for our comprehensive analysis and investment recommendation.